Thank you for your thoughts ..
My Thesis in investing vktx is simple
1- small biotech are in favor now . No point investing when wind is against sail
2- mdgl is valued now $12 a share in vktx terms .. their drug in same class and same progress level
For me question wss to invest before or after hip data
I see littl change we get bad hip data over next weeks
If it drags to mid November , we may not have good data